Transcriptomics

Dataset Information

0

Generation of highly proliferative rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy


ABSTRACT: Adoptive immunotherapy has emerged as a powerful approach to cure cancer and chronic infections. Currently, the generation of a massive number of T cells that provide long-lasting immunity is challenged by exhaustion and differentiation-associated senescence, which inevitably arise during in vitro cloning and expansion. To circumvent these problems, several studies have proposed an induced pluripotent stem cell (iPSC)-mediated rejuvenation strategy to revitalize the exhausted/senescent T-cell clones. Because iPSC-derived cytotoxic T lymphocytes (iPSC-CTLs) generated via commonly used monolayer systems have unfavorable innate-like features such as aberrant natural killer (NK) activity and limited replication potential, we modified the redifferentiation culture to generate CD8ab+CD5+CCR7+CD45RA+CD56- adaptive iPSC-CTLs. The modified iPSC-CTLs exhibited early memory phenotype, including high replicative capacity and the ability to give rise to potent effector cells. In expansion culture with an optimized cytokine cocktail, iPSC-CTLs proliferated more than 10^15-fold in a feeder-free condition. Our redifferentiation and expansion package of early memory iPSC-CTLs could supply memory and effector T cells for both autologous and allogeneic immunotherapies.

ORGANISM(S): Homo sapiens

PROVIDER: GSE173377 | GEO | 2021/04/27

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-12-02 | E-GEOD-51393 | biostudies-arrayexpress
2024-03-20 | GSE235604 | GEO
2016-11-15 | GSE81975 | GEO
2024-10-17 | PXD050084 | Pride
2011-09-29 | E-GEOD-27337 | biostudies-arrayexpress
2022-09-02 | PXD036457 | Pride
2011-09-30 | GSE27337 | GEO
2019-10-23 | GSE135141 | GEO
2022-10-04 | GSE214599 | GEO
2021-02-25 | GSE161842 | GEO